Literature DB >> 27168435

Clinical Implications of Genomic Discoveries in Lung Cancer.

Charles Swanton1, Ramaswamy Govindan1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27168435     DOI: 10.1056/NEJMra1504688

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  91 in total

1.  Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer.

Authors:  Jin Kyung Rho; In Yong Lee; Yun Jung Choi; Chang-Min Choi; Jae-Young Hur; Jong Sung Koh; Jaekyoo Lee; Byung-Chul Suh; Ho-Juhn Song; Paresh Salgaonkar; Jungmi Lee; Jaesang Lee; Dong Sik Jung; Sang-Yeob Kim; Dong-Cheol Woo; In-Jeoung Baek; Joo-Yong Lee; Chang Hoon Ha; Young Hoon Sung; Jeong Kon Kim; Woo Sung Kim; Joon Seon Song; Cheol Hyeon Kim; Trever G Bivona; Jae Cheol Lee
Journal:  Cancer Res       Date:  2017-01-12       Impact factor: 12.701

2.  Modulation of Mutant KrasG12D -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function.

Authors:  Xiaorong Zhou; Mahesh S Padanad; Bret M Evers; Bethany Smith; Nicole Novaresi; Shruthy Suresh; James A Richardson; Emily Stein; Jingfei Zhu; Robert E Hammer; Kathryn A O'Donnell
Journal:  Mol Cancer Res       Date:  2018-11-08       Impact factor: 5.852

3.  Recalcitrant small cell lung cancer: the argument for optimism.

Authors:  Karen G Zeman; Christina E Brzezniak; Corey A Carter
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

Authors:  Oliver Gautschi; Julie Milia; Thomas Filleron; Juergen Wolf; David P Carbone; Dwight Owen; Ross Camidge; Vignhesh Narayanan; Robert C Doebele; Benjamin Besse; Jordi Remon-Masip; Pasi A Janne; Mark M Awad; Nir Peled; Chul-Cho Byoung; Daniel D Karp; Michael Van Den Heuvel; Heather A Wakelee; Joel W Neal; Tony S K Mok; James C H Yang; Sai-Hong Ignatius Ou; Georg Pall; Patrizia Froesch; Gérard Zalcman; David R Gandara; Jonathan W Riess; Vamsidhar Velcheti; Kristin Zeidler; Joachim Diebold; Martin Früh; Sebastian Michels; Isabelle Monnet; Sanjay Popat; Rafael Rosell; Niki Karachaliou; Sacha I Rothschild; Jin-Yuan Shih; Arne Warth; Thomas Muley; Florian Cabillic; Julien Mazières; Alexander Drilon
Journal:  J Clin Oncol       Date:  2017-03-13       Impact factor: 44.544

5.  MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.

Authors:  Wei Jiang; Ke Wei; Chunfeng Pan; Hong Li; Jing Cao; Xu Han; Yu Tang; Shichao Zhu; Weiwei Yuan; Yaozhou He; Yang Xia; Liang Chen; Yijiang Chen
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

6.  Rebuttal from Dr. Hofman and Dr. Ilié.

Authors:  Marius Ilié; Paul Hofman
Journal:  Transl Lung Cancer Res       Date:  2016-08

7.  Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.

Authors:  Erin M Parry; Dustin L Gable; Susan E Stanley; Sara E Khalil; Valentin Antonescu; Liliana Florea; Mary Armanios
Journal:  J Thorac Oncol       Date:  2017-08-24       Impact factor: 15.609

Review 8.  New Approaches to SCLC Therapy: From the Laboratory to the Clinic.

Authors:  John T Poirier; Julie George; Taofeek K Owonikoko; Anton Berns; Elisabeth Brambilla; Lauren A Byers; David Carbone; Huanhuan J Chen; Camilla L Christensen; Caroline Dive; Anna F Farago; Ramaswamy Govindan; Christine Hann; Matthew D Hellmann; Leora Horn; Jane E Johnson; Young S Ju; Sumin Kang; Mark Krasnow; James Lee; Se-Hoon Lee; Jonathan Lehman; Benjamin Lok; Christine Lovly; David MacPherson; David McFadden; John Minna; Matthew Oser; Keunchil Park; Kwon-Sik Park; Yves Pommier; Vito Quaranta; Neal Ready; Julien Sage; Giorgio Scagliotti; Martin L Sos; Kate D Sutherland; William D Travis; Christopher R Vakoc; Sarah J Wait; Ignacio Wistuba; Kwok Kin Wong; Hua Zhang; Jillian Daigneault; Jacinta Wiens; Charles M Rudin; Trudy G Oliver
Journal:  J Thorac Oncol       Date:  2020-02-01       Impact factor: 15.609

9.  PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

Authors:  Xiaorong Zhou; Barrett L Updegraff; Yabin Guo; Michael Peyton; Luc Girard; Jill E Larsen; Xian-Jin Xie; Yunyun Zhou; Tae Hyun Hwang; Yang Xie; Jaime Rodriguez-Canales; Pamela Villalobos; Carmen Behrens; Ignacio I Wistuba; John D Minna; Kathryn A O'Donnell
Journal:  Cancer Res       Date:  2016-11-07       Impact factor: 12.701

10.  Genomic Characterization of NSCLC in African Americans: A Step Toward "Race-Aware" Precision Medicine.

Authors:  Hirva Mamdani; Ann G Schwartz
Journal:  J Thorac Oncol       Date:  2020-12       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.